Complete blood count results were normal at the referring hospital, whereas serum biochemical examinations showed a slight increase in alkaline phosphatase (160 U/L, reference range: 089 U/L) and blood urea nitrogen (36.0 mg/dL, reference range: 9.229.2 mg/dL) levels
The occurrence of metabolic syndrome in postmenopausal women is 23 times more likely than in premenopausal women [42]
The mean changes from baseline to Week 26 were -0.5 kg, -3.1 kg and -4.4 kg in the placebo, liraglutide 1.8 mg and semaglutide tablets 14 mg arms, respectively
If you develop gastrointestinal symptoms that might affect absorption, your thyroid function should be monitored
Most GLP-1 receptor agonists are administered via subcutaneous injection, with dosing frequencies ranging from daily to once weekly depending on the specific agent
GLP-1 medications may be appropriate for: Adults with type 2 diabetes Individuals with obesity (BMI 30) Individuals with overweight (BMI 27) plus weight-related conditions Patients with insulin resistance or metabolic syndrome They are not cosmetic weight-loss drugs and should not be used casually